PharmaVoice 100: Page 2

  • Cancer care visionaries, PharmaVoice 100
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip
    PharmaVoice 100

    PharmaVoice 100s: Cancer care visionaries

    Leaders shaping the future of oncology and cancer care through grit and determination in the face of one of healthcare’s greatest challenges.

    By Michael Gibney • Oct. 2, 2023
  • PharmaVoice 100 trailblazers
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip

    The PharmaVoice 100: Trailblazers

    Leaders who are going where no biopharma executive has gone before and changing the industry along the way.

    By Michael Gibney • Sept. 29, 2023
  • Silhouette of people in business attire in front of a wall of windows
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip
    PharmaVoice 100

    PharmaVoice 100s: Standout execs

    Leaders who’ve created unique strategies for thriving amid the heavy headwinds facing the industry.

    By • Sept. 25, 2023
  • PharmaVoice 100 header
    Image attribution tooltip

    Illustration: Deena So Oteh for Industry Dive

    Image attribution tooltip

    The 2023 PharmaVoice 100

    This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

    By • Sept. 19, 2023
  • leaders hands
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Catching up with 2022 PharmaVoice 100 honorees

    Tapping into our growing community for expertise and inspiration.

    By • Sept. 13, 2023
  • leadership
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    PharmaVoice 100

    The PharmaVoice 100 — Who makes the cut

    What we’re looking for in each new class of honorees.

    By • March 15, 2023
  • silhouette people
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    PharmaVoice 100 honorees: Where are they now?

    How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles. 

    By , Karissa Waddick • March 3, 2023
  • lightbulb breaking
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    By • Dec. 2, 2022
  • pills
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By • Nov. 30, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Image attribution tooltip
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By • Nov. 11, 2022
  • brand
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Opinion

    What’s your leadership brand?

    Pharma industry leaders share their brand personas.

    By • Oct. 14, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    By PharmaVoice staff • Sept. 15, 2022
  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

    By PharmaVoice staff • Sept. 15, 2022
  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice
    Image attribution tooltip

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

    Sept. 15, 2022
  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

    By PharmaVoice staff • Sept. 15, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    By PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip
    Profile

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Abigail Jenkins framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Abigail Jenkins
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Abigail Jenkins

    With the belief that empathy is critical to leadership, the former chief commercial and business officer of Lyndra Therapeutics has a strong track record of building teams and accelerating progress.

    By • Sept. 6, 2022
  • A portrait of Dr. Helen Thackray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Helen Thackray
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Helen Thackray

    The chief research and development officer at BioCryst Pharmaceuticals is leaning into decades of experience to advance a promising pipeline of rare disease products.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of John Tsai framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Tsai
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. John Tsai

    How the former president of global drug development and chief medical officer at Novartis funneled his curiosity for engineering into a bold new approach to drug development.

    By • Sept. 6, 2022
  • A portrait of Henrietta Ukwu framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Henrietta Ukwu
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Henrietta Ukwu

    Novavax’s regulatory head helped the company pull off its first approvals with the FDA and the EMA — but her accomplishments in pharma run deep.

    By • Sept. 6, 2022
  • A portrait of Samantha Du framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Du
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Samantha Du

    The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.

    By • Sept. 6, 2022
  • A portrait of John Oyler framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Oyler
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: John Oyler

    The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.

    By • Sept. 6, 2022
  • A portrait of Johnna Wesley framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Johnna Wesley
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Johnna Wesley

    The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Jeremy Levin framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jeremy Levin
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Jeremy Levin

    Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics has demonstrated that he is a patient advocate, scientist, clinician and innovator at heart.

    By PharmaVoice staff • Sept. 6, 2022